# FDA recall D-0366-2024

> **Eugia US LLC** · Class II · drug recall initiated 2024-02-20.

## Product

Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01

## Reason for recall

Failed Dissolution Specifications

## Distribution

OH, TN, LA, MS

## Key facts

- **Recall number:** D-0366-2024
- **Recalling firm:** Eugia US LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2024-02-20
- **Report date:** 2024-03-13

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Windsor, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0366-2024

## Citation

> AI Analytics. FDA recall D-0366-2024. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0366-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*